Skip to content

Quantitative analysis of the information of the abdomen-ren meridian in patients with diminished ovarian reserve

Quantitative analysis of the information of the abdomen-ren meridian in patients with diminished ovarian reserve

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000631
Enrollment
Unknown
Registered
2024-10-30
Start date
2023-07-10
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve

Interventions

diminished ovarian reserve patients:Detection of six sex hormones
Hyperspectral imaging : The Canadian Photon hyperspectral imager was used for research. The spectral wavelength range was 400-1000 nm and the spectral accuracy was 1 nm. In this study, cube imaging mo
healthy volunteers:Detection of six sex hormones

Sponsors

Institute of acupuncture and moxibustion China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: Healthy adult women ( 1 ) There was no confirmed systemic disease recently ; ( 2 ) Abdominal skin health ; ( 3 ) 22 = age < 40 ; ( 4 ) Voluntary to participate in the trial and signed informed consent. DOR patients ( 1 ) Conform to the diagnostic criteria ; ( 2 ) 22 = age < 40 ; ( 3 ) Voluntary to participate in the trial and signed informed consent.

Exclusion criteria

Exclusion criteria: ( 1 ) Complicated with related diseases affecting conception ( any one ) : congenital reproductive organ dysplasia untreated endometrial polyps untreated uterine cavity infection untreated hydrosalpinx thin endometrium uterine fibroids endometriosis or other organic diseases ; ( 2 ) Combined with polycystic ovary syndrome ; ( 3 ) Metabolic endocrine diseases such as uncorrected hyperprolactinemia hyperandrogenism thyroid dysfunction and chronic adrenal insufficiency ; ( 4 ) patients with severe cardiovascular and cerebrovascular diseases liver kidney malignant tumors hematopoietic system diseases systemic immune system diseases and mental diseases ; ( 5 ) There were tattoos scars and skin diseases in the abdominal detection site ; ( 6 ) with severe heart liver and kidney dysfunction ; ( 7 ) have serious cognitive mental disorders can not cooperate with the test ; ( 8 ) Lactating women.

Design outcomes

Primary

MeasureTime frame
Luteinizing hormone;Estradiol;Hyperspectral imaging ;Follicle stimulating hormone levels;

Countries

China

Contacts

Public ContactYigong Fang

Institute of acupuncture and moxibustion China Academy of Chinese Medical Sciences

fangyigong@163.com+86 135 2017 5177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026